Numerous health and safety violations related to the practice of pharmacy at the New England Compounding Center, Framingham, Mass. have been documented by investigators of the Massachusetts Department of Public Health and FDA, according to Madeleine Biondolillo, MD, in a press conference Oct. 23.
FDA’s Recent Exemptions: What Do They Mean as We Finalize DSCSA Implementation?
October 31st 2024Kala Shankle, Vice President of Regulatory Affairs with the Healthcare Distribution Alliance, and Ilisa Bernstein, President of Bernstein Rx Solutions, LLC, discussed recent developments regarding the Drug Supply Chain Security Act.